New starters at Double Helix
February 25, 2010Sales and Marketing Double Helix, appointment, sales and marketing
Healthcare consultancy Double Helix has appointed Amanda Siebols (pictured) as a research consultant and Ioanna Maraki as a research executive. …
Obama ‘closer than ever’ to health reform
February 25, 2010Sales and Marketing Obama, US healthcare
The continuing showdown over health insurance reform in the US reaches its next potential flashpoint today (Thursday) with what is …
Merck KGaA posts modest revenue increase
February 24, 20102009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif
German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth. Revenues increased 2.1% to 7.7 …
Sudler & Hennessey promotes Max Jackson
February 24, 2010Medical Communications Sudler & Hennessey, appointment, medical communications
Max Jackson has been promoted to chief executive, EMEA and APAC, at advertising agency Sudler & Hennessey (S&H). In his …
Avastin fails in phase III study
February 24, 2010Research and Development Roche, avastin, gastric cancer, stomach cancer
Roche’s Avastin does not help patients with a severe form of stomach cancer to live longer, according to the results …
NICE approves Yondelis
February 24, 2010Sales and Marketing NICE, PharmaMar, Yondelis
Cancer drug Yondelis has been approved by NICE for use on the NHS, but only after the manufacturer offered to …
NHS Alliance finds its own third way
February 24, 2010NHS, NHS Alliance
The NHS Alliance has proposed a new business model for the NHS that would draw on the health service’s founding …
Methylene blue poised to move into the clinic
February 24, 2010Manufacturing and Production, Research and Development Novasep, ProveBlue, Provepharm, malaria
A new purer form of the reagent methylene blue could take the compound out of the testing laboratory and into …
New role for McCann’s Andrew Berrie
February 24, 2010Medical Communications McCann Healthcare, appointment, medical communications
Andrew Berrie’s roll within McCann Healthcare Worldwide’s Medical Communications arm has been enlarged. His remit will now also include being …
Predatory Icahn moves in on weakened Genzyme
February 23, 2010Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn
Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …
Reports raise fresh Avandia safety questions
February 23, 2010Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes
GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …
Baroness Thornton joins the Department of Health
February 23, 2010DH, UK, appointment
Baroness Thornton has been appointed parliamentary under-secretary of state at the Department of Health. Prior to this she was government …
Pfizer, Lilly and Merck partner for cancer research
February 23, 2010Research and Development Asia, Cancer, developing world, em, emerging markets
Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …
Digital Pharma: Searching for clinical trials
February 23, 2010Research and Development CRO, TrialReach, digi, digital pharma, digital pharma research, digital research, patient recruitment
A new clinical trials search and referral engine has launched to help patients who are considering taking part in a …
Shire readies Gaucher drug Vpriv
February 23, 2010Manufacturing and Production Cerezyme, Gaucher's, Shire, Vpriv
Shire Pharmaceuticals says it has already manufactured enough of its Vpriv to treat around 400 Gaucher disease patients and could …
Lilly UK appoints Ramona Sequeira managing director
February 23, 2010Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing
Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …
Low Adderall sales hit Shire
February 22, 2010Sales and Marketing 2009 financials, Adderall, Shire
Shire has posted negative growth due to generic competition for its flagship ADHD drug Adderall XR. Product sales were down …
Novartis gains edge in MS treatment race
February 22, 2010Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis
Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …
Sanofi’s Humenza poised to be Europe’s fifth swine flu vaccine
February 22, 2010Sales and Marketing Sanofi Pasteur, Tyverb, Zeftera, swine flu
Sanofi Pasteur’s Humenza is set to become the fifth swine flu vaccine in Europe after gaining the support of a …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
